food and drug administration

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Sadly, the big news this week is vaping.  Hundreds are sick and several have died, apparently as a result of using e-cigarettes and other vaping products.  As a result, the cannabis industry expects fallout from this

CBD is “thriving” in the current regulatory environment, but is it doing so illegally?

As former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb opined last  week, “the CBD craze is getting out of hand. The FDA needs to act.”  Since the passage of the Farm Bill in December of 2018, there has been a marked uptick in interest in the cannabidiol (CBD) space from businesses and users alike.  Congress explicitly preserved the FDA’s authority to regulate CBD-containing products to ensure that they are safe and that their claims are valid.  Current federal law expressly allows for the distribution of hemp-derived CBD products that contain 0.3% tetrahydrocannabidiol (THC) or less to be sold, with certain caveats.  The FDA has provided clarity that hulled hemp seed, hemp protein powder, and hemp seed oil can be legally used in foods.  Other CBD products, however, are still subject to various state law regulations as well as the U.S. Food, Drug, and Cosmetic Act (FD&C Act), which requires FDA pre-market approval for drug products.  Currently, the FDA treats CBD products aimed at human or animal consumption as drugs and therefore they cannot be distributed without prior approval or a rulemaking exception (more on this below).  The following is a brief update on recent developments within the federal regulatory regime of CBD products. 
Continue Reading

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Let’s start with Congress, which had a very busy week.  On Tuesday, the Senate Banking Committee had a hearing on cannabanking.  Full video, as well as member statements and witness testimony are available at the

In Dallas, a yoga studio offers CBD-infused kombucha.

In Philadelphia, a decorated chef serves an elegant CBD-infused four-course meal to a nattily dressed group of fifty.

In Kentucky, the Peaches & CBD Cream burger competes in Lexington Burger Week.

A vendor at an arts festival in Colorado offers CBD Hot Dogs from his hot dog cart.

In Minnesota, a brewer offers a pint of craft beer that contains 13mg of CBD.
Continue Reading

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

First, a point of personal pride.  The Blunt Truth started in February 2016, with the slightly crazy idea that a BigLaw firm could talk about marijuana on a regular basis.  As of this week, we’ve

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

Our weekly review starts in Georgia, where the governor is expected to sign a medical marijuana reform bill into law.  The law will allow grow houses and production facilities in the state, which will be heavily

Cannabidiol (CBD) competed with Vitamin C as a top ingredient in new cosmetic products this past year, with promises of having anti-inflammatory effects and other healing properties. Amid the hype, at the end of 2018, the Agriculture Improvement Act of 2018, P.L. 115-334 (the “2018 Farm Bill”) was signed into law, changing the marketing of hemp and derivatives of cannabis and further removing hemp from the Controlled Substances Act thereby making it no longer an illegal substance under federal law. See Section 297A. The 2018 Farm Bill amended the definition of “hemp” to specifically include “all derivatives, extracts, cannabinoids,” which has been construed as an attempt to include hemp-based CBD under the definition of industrial hemp. The 2018 Farm Bill allows, subject to certain restrictions, hemp cultivation, along with the sale, transport (including via interstate commerce), and possession of hemp-derived products.
Continue Reading

Welcome to our end of the year wrap-up post for The Week in Weed; it’s hard to believe another year has come and (almost) gone, but the calendar doesn’t lie.  In what we are calling an homage to Dave Barry and his always hilarious Year in Review, we’ll organize these stories by month.

Without further ado, here’s a look at the stories that grabbed our attention in 2018.
Continue Reading